Somewhat Favorable Media Coverage Somewhat Unlikely to Affect Stericycle (SRCL) Stock Price
News coverage about Stericycle (NASDAQ:SRCL) has been trending somewhat positive this week, according to Accern Sentiment. Accern ranks the sentiment of news coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Stericycle earned a media sentiment score of 0.19 on Accern’s scale. Accern also assigned media headlines about the business services provider an impact score of 45.4401246316767 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
Here are some of the media headlines that may have effected Accern Sentiment’s rankings:
- Zacks: Analysts Anticipate Stericycle Inc (SRCL) Will Announce Quarterly Sales of $880.51 Million (americanbankingnews.com)
- Comprehensive Stock Analysis – Stericycle Inc (NASDAQ: SRCL) – Alpha Beta Stock (alphabetastock.com)
- FY2018 EPS Estimates for Stericycle Inc (SRCL) Raised by Analyst (americanbankingnews.com)
- Stericycle (SRCL) Shares Cross Above 200 DMA (nasdaq.com)
- Stericycle (SRCL) Stock Rating Upgraded by BidaskClub (americanbankingnews.com)
Shares of Stericycle (NASDAQ:SRCL) traded down $2.66 during trading on Monday, hitting $70.72. The stock had a trading volume of 1,210,204 shares, compared to its average volume of 761,825. The stock has a market capitalization of $6,264.66, a price-to-earnings ratio of -124.07, a price-to-earnings-growth ratio of 1.78 and a beta of 0.26. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.93. Stericycle has a 52-week low of $61.25 and a 52-week high of $88.00.
A number of equities research analysts have commented on SRCL shares. Royal Bank of Canada decreased their price target on Stericycle from $74.00 to $67.00 and set an “underperform” rating on the stock in a report on Thursday, November 9th. Stifel Nicolaus reissued a “buy” rating and set a $85.00 price target on shares of Stericycle in a report on Thursday, December 28th. BMO Capital Markets decreased their price target on Stericycle from $74.00 to $62.00 and set a “market perform” rating on the stock in a report on Friday, November 10th. Jefferies Group set a $108.00 price target on Stericycle and gave the company a “buy” rating in a report on Tuesday, October 17th. Finally, Oppenheimer reissued a “hold” rating on shares of Stericycle in a report on Wednesday, December 13th. Two equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and six have issued a buy rating to the stock. Stericycle presently has an average rating of “Hold” and an average target price of $76.09.
In related news, Director Mark C. Miller sold 19,753 shares of Stericycle stock in a transaction dated Monday, November 27th. The stock was sold at an average price of $63.33, for a total value of $1,250,957.49. Following the completion of the transaction, the director now owns 205,854 shares in the company, valued at $13,036,733.82. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In the last 90 days, insiders have sold 59,259 shares of company stock valued at $3,847,687. Company insiders own 3.50% of the company’s stock.
Stericycle Company Profile
Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.